Dr. Joseph Fraiman of Thibodaux Regional Health Center in Louisiana, and clinical scientist has confirmed an increase in excess mortalities due to the mRNA covid vaccine. (1) Based on an article he co-authored,as lead author, and published in August, 2022, from a peer reviewed study, Fraiman concluded that the vaccine increase serious adverse events at a rate of 12.5 per 10,000 vaccinated. (2) At the time of publication they felt that study did not warrant the withdrawal of the mRNA vaccine.
In a more recent study published by BMJ regarding the FDA’s surveillance data, There was a statistically significant increase in Guillain-Barré syndrome within 42 days after the first dose of the AstraZeneca vaccine, with 190 observed events compared to the 76 expected (ratio 2.49; 95% CI 2.15 to 2.87). A significant increased risk of CVST was also noted after the first AstraZeneca dose (ratio 3.23; 95% CI 2.51 to 4.09). (3)
The study confirmed higher risks of myocarditis after Pfizer and Moderna doses and pericarditis after certain doses of the Moderna and AstraZeneca vaccines within 42 days of vaccination. Additionally, there were potential safety signals for acute disseminated encephalomyelitis (ADEM) and transverse myelitis with both viral vector and mRNA vaccines.
A second study involving 6.7 million people in Australia found an increased risk of ADEM (relative incidence 3.74; 95% CI 1.02 to 13.70) and transverse myelitis (dose 1 RI 2.49; 95% CI 1.07 to 5.79) with the AstraZeneca vaccine, but no associations with mRNA vaccines. The absolute risk of ADEM was 0.78 per million doses and of transverse myelitis was 1.82 per million doses. Researchers emphasized that these small risks should be weighed against the significant benefits of COVID-19 vaccination.
Lead author Kristýna Faksová highlighted that the large population size of the study increased the ability to detect rare vaccine safety signals, which smaller studies might miss.
References:
Comments